Invention Grant
US08106063B2 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
失效
嘧啶酰胺衍生物作为趋化因子受体调节剂
- Patent Title: Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
- Patent Title (中): 嘧啶酰胺衍生物作为趋化因子受体调节剂
-
Application No.: US12508934Application Date: 2009-07-24
-
Publication No.: US08106063B2Publication Date: 2012-01-31
- Inventor: Mark Ebden , Premji Meghani , Colin Bennion , Anthony Ronald Cook , Roger Victor Bonnert
- Applicant: Mark Ebden , Premji Meghani , Colin Bennion , Anthony Ronald Cook , Roger Victor Bonnert
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: Fish & Richardson P.C.
- Priority: GB0217431.6 20020727
- Main IPC: A61K31/505
- IPC: A61K31/505 ; A61K31/506 ; A61P11/06 ; A61P17/06 ; A61P19/02 ; A61P35/00 ; C07D239/46 ; C07D403/12 ; C07D403/14 ; C07D413/12 ; C07D413/14 ; C07D407/12 ; C07D407/14 ; C07D409/12 ; C07D409/14 ; C07D405/12 ; C07D405/14
Abstract:
A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.
Public/Granted literature
- US20100063079A1 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators Public/Granted day:2010-03-11
Information query
